Digest

Bryan Cave Digest

ARCHIVE

Main Content

Update: Canada Poised to Respond if COOL Requirements Stay As Is in the Farm Bill

A decision has not come down from the U.S. Court of Appeals regarding the USDA’s Country of Origin Labeling “COOL” law , but Canada is positioning itself to launch a trade-war with the United States just in case.

Earlier this week, the Farm Bill was passed by the House of Representatives and made its way to the Senate for approval.  A Senate vote is expected next week, but Canadians are not hopeful for an amicable settlement as the House did not make any substantive changes to the country of original labeling requirements.

Since 2008, when COOL was initially adopted, Canada has dissented, claiming that the it is far too costly and injures the meat industry.  Gerry Ritz and Ed Fast, Canada’s Federal Agriculture Minister and International Trade Minister made the following combined statement:

“By refusing to fix country-of-origin labelling, the U.S. is effectively legislating its own citizens out of

FDA Issues Proposed Food Transportation Rule

January 31, 2014

Categories

On January 31, 2014, as part of the ongoing rulemaking changes required by the Food Safety Modernization Act, FDA issued a proposed rule relating to the sanitary transportation of human and animal food.  The rule will require “certain shippers, receivers, and carriers who transport food by motor or rail vehicles to take steps to prevent the contamination of human and animal food during transportation.”  The rule also creates criteria for sanitary practices, including refrigeration, vehicle cleaning, protecting food during transportation and training and recordkeeping.  Comments are due by May 31, 2014.  Stay tuned to Digest for more commentary about the proposed rule.

FDA Extends Animal Food Rule Comment Period

FDA has announced that it is extending the comment period on its proposed rule regarding Current Good Manufacturing Practices and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals until March 31, 2014.  FDA is also extending the comment period on the related Draft Qualitative Risk Assessment of Risk of Activity/Animal Food Combinations for Activities (Outside the Farm Definition) Conducted in a Facility Co-Located on a Farm to the same date.

Gear Up for the FDA’s Menu Labeling Regulations

Gear Up for the FDA’s Menu Labeling Regulations

January 23, 2014

Authored by: Sara Ahmed

The FDA’s highly anticipated proposed rules regarding menu labeling are set for release just around the corner, and businesses and elected officials are already reacting.

The proposed rules apply to chain restaurants, retail food establishments, and vending machines with 20 or more locations and require that menus be labeled with caloric information and that certain nutritional information be made readily available to patrons.

While some chain retailers applaud the idea of nationwide uniform labeling requirements for the sake of ease, others are concerned about the cost and efficacy of the proposed rules.

Domino’s CEO J. Patrick Doyle has been a dissonant voice in the debate since 2011.  Maine’s Senator Angus King is another critic, and joining him are both members of the Senate and House that have sponsored S. 1756 and H.R. 1249 , bills aimed at amending the FD&C Act.  Congresswoman Renee Ellmers, who supports the amendment, claims that the FDA’s proposed “one-size-fits-all

Bryan Cave Obtains Dismissal of Nutritional Supplement Patent Infringement Litigation

January 20, 2014

Categories

Bryan Cave has been in the news recently for its representation of Pinnaclife Inc., regarding patent protection for nutritional supplements.  A California federal trial court judge dismissed claims that Pinnaclife infringed CreAgri Inc.’s patents for olive-based, anti-inflammatory supplements, ruling that CreAgri didn’t know the supplement would reduce inflammation when it filed the patent. San Francisco Partner Lee Marshall was quoted saying that Pinnaclife was glad the court recognized the importance of data in designing nutritional products. Litigation over nutritional supplements is increasing, he said, and many supplement patents lack the analytical rigor of pharmaceutical drugs. “If you have a nutritional supplement or a pharmaceutical drug, and you think it’s going to work, that’s not enough to get a patent,” Marshall said. “You need good data to demonstrate efficacy.”

The case is CreAgri Inc. v. Pinnaclife Inc., Case No. 5:11-cv-06635 in the United states District Court for the Northern District of California.

Want to Export Diary Products to China?

January 20, 2014

Categories

China has recently modified the requirements for imports of milk and dairy products into the country, and FDA is working to assist US producers and manufacturers compete in the Chinese market.  FDA has begun preparing a list of milk product manufacturers and producers who want to export into China, as China has indicated that products from manufacturers and producers not on the list may be denied entry into China.  For purposes of this list, “milk product” does not include raw milk, but does otherwise include milk products as identified in 21 C.F.R. 1240.3(j).

Participation in the list is voluntary, and interested entities “cannot be subject to any pending judicial enforcement action or a pending FDA warning letter, and would need to either have had a FDA inspection within 3 years, or be on the Interstate Milk Shippers List or the U.S. Department of Agriculture list, Dairy Plants Surveyed and

The attorneys of Bryan Cave LLP make this site available to you only for the educational purposes of imparting general information and a general understanding of the law. This site does not offer specific legal advice. Your use of this site does not create an attorney-client relationship between you and Bryan Cave LLP or any of its attorneys. Do not use this site as a substitute for specific legal advice from a licensed attorney. Much of the information on this site is based upon preliminary discussions in the absence of definitive advice or policy statements and therefore may change as soon as more definitive advice is available. Please review our full disclaimer.